The research in the area of one-pot chemoenzymatic cascades is rapidly progressing.
INTRODUCTION
The idea of combining enzymes with suitable chemical catalysts in one-pot reactions has been a focus of researchers to a large extent over the past 10 years as one of the tools for producing interesting and valuable substances under mild conditions. One-pot processes benefit from the fact that usually there is no need for intermediate recovery, purification steps and the use of protective groups or reagents (Schoevaart and Kieboom 2002) ; therefore, several operational steps are omitted. In the pioneering work in this field, glucose isomerase was combined with a heterogeneous platinum catalyst for the one-pot conversion of a mixture of D-glucose and D-fructose into D-mannitol in aqueous conditions. It was the first time the compatibility of chemo-and biocatalysis was demonstrated in a tandem one-pot process (Makkee et al. 1980) . Biocatalysis is, nowadays, a partner, rather than a rival of the chemocatalysts. Since biocatalysts usually operate in aqueous environments, and thus contribute to replacing organic solvents, applying enzymes and whole cells to particular chemical processes might reduce their E-factors, which represent the environmental compatibility and complexity of the synthesis (Woodley 2008) . Gröger and Hummel (2014) reviewed the currently-known one-pot processes in aqueous medium, combining metal/organocatalysis with biocatalysis. Although tandem and sequential one-pot reactions with bio-and chemocatalysts broaden the portfolio of organic synthesis, it is noteworthy to say that whole cells are rather an exception (Ema et al. 2008; Fuchs et al. 2011; Liu et al. 2009; Szymanski et al. 2010 ) and mostly free enzymes have been involved in these processes.
However, whole cells are used in 75% of industrially implemented redox biotransformations, when often cofactor regeneration is necessary and/or the enzyme is not stable outside the cell.
Generally, whenever whole cells can be used, the process is economically more attractive compared to the use of isolated enzymes (Carballeira et al. 2009; Solano et al. 2012 ).
Enantioselective recombinant mutants of monoamine oxidase MAO-N have been derived from the same wild-type sequence by directed evolution combined with rational design and high-throughput screening methods (Ghislieri et al. 2013a; 2013b; Heath et al. 2014; Turner 2009; Turner 2011) . By deracemization of a broad range of amine substrates facilitated by MAO-N, a variety of intermediates and structure motifs for the pharmaceutical and agrochemical industries are produced, including boceprevir for the treatment of hepatitis C (Li et al. 2012) . The production of chiral amines from racemic mixtures of primary (Alexeeva et al. 2002) , secondary (Carr et al. 2003) and tertiary (Dunsmore et al. 2006 ) amines is performed as a one-pot chemo-biocatalysed reaction involving MAO-N for the stereoselective oxidative step and usually amine borane complex as the non-specific reducing agent, although recently a new way for deracemization has been proposed by combining amine oxidase and imine reductase enabling one-pot process performance (Heath et al. 2016 ).
The MAO-N variants D9 and D11 differ by a single point mutation (H430G), which results in the increased active site volume of the D11 variant, allowing for the binding of sterically demanding substrates (Ghislieri et al. 2013a; 2013b) . 1,2,3,4-tetrahydroisoquinolines and 3,4-dihydroisoquinoline-1(2H)-ones were identified as potent and selective inhibitors of Kinase insert Domain containing Receptor (KDR). Small molecules inhibiting KDR kinase activity might prospectively be used in the clinic to treat human tumors (Choquette et al. 2008 ).
The aim of this work is to develop a one-pot chemo-biocatalytic transformation of the amine 1,2,3,4-tetrahydroisoquiniline to the lactam 3,4-dihydroisoquinoline-1(2H)-one using whole cells expressing MAO-N in combination with CuI/H2O2 in order to produce a structure pattern that might potentially be further used in the synthesis of KDR inhibitors.
MATERIALS AND METHODS

Microorganisms
Monoamine oxidase mutants MAO-N D9 and MAO-N D11, harbored in plasmid pET16b, were developed and kindly provided by the team of Prof. Nicholas Turner (Manchester Institute of Biotechnology, University of Manchester, UK). The plasmids were transformed to three different E. coli strains of chemically competent cells: BL21(DE3) Gold (Stratagene, NL), Lemo21(DE3) (New England Biolabs, CA) and OverExpress C43(DE3) (Lucigen, USA), according to manufacturers´ protocols. Preliminary small-scale expression studies to select the best strain for MAO-N expression were performed according to the manufacturers´ recommendations, followed by SDS-PAGE detection of protein expression and activity testing (section Biotransformation). Protein quantification was carried out using the Bradford method with bovine serum albumin as a standard.
Biomass production and expression of MAO-N
Unless stated otherwise, all chemicals were purchased from Sigma Aldrich and the solvents were of HPLC grade. Besides the small-scale preliminary expression studies, larger cell batches (especially of E. coli OverExpress C43(DE3)) were produced in an autoinduction medium according to Schrittwieser et al. (2014) procedures. The stock solutions were sterilised separately and were mixed to get the proper composition of the medium prior to inoculation. The inoculum was prepared in LB medium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) containing 100 μg/mL ampicillin from the pre-inoculation overnight culture at 37 °C and 250 rpm. When the OD600nm was in the range of 0.6-1, 400 mL of the autoinduction medium in 2 L Erlenmeyer flasks was inoculated with 1% (v/v) of the inoculation culture. For the first 20 h, the cultivation was performed in the rotatory shaker at 30 °C and 150 rpm in the presence of 100 μg/mL ampicillin, and then the temperature was lowered to 25 °C. The overall cultivation time was 70-72 h. The biomass was centrifuged (2750 g, 30 min, 4 °C), and the pellet was resuspended in 1/10th of the original volume in potassium phosphate buffer (0.1 M, pH 7.8) and centrifuged again. The biomass was stored at -20 °C until use.
Cell lysates preparation
2 mL of the fermentation broth of known OD600 were centrifuged (4942 g, 4 °C, 15 min). The pellet was re-suspended in 400 μL potassium phosphate buffer (0.1 M, pH 7.8) and the cell suspension was sonicated for 10 on/off cycles of 10 seconds at an amplitude of 10 μm using the Soniprep 150 sonicator (MSE, Sanyo, Japan). If a higher amount of lysate was required, the volumes were proportionally higher. The lysate was centrifuged (4942 g, 4 °C, 15 min) and the supernatant was used for further analysis.
Biotransformation
1,2,3,4-tetrahydroisoquinoline (THIQ, 95%, Sigma Aldrich) was selected as the model substrate for biological oxidation using MAO-N as a biocatalyst. Probably due to spontaneous oxidation, THIQ contains ~2.5% 3,4-dihydroisoquinoline (DHIQ), which was not taken into account in the calculations. To obtain 10 mL of the 100 mM substrate stock solution, 131.4 µL THIQ was dissolved in 1.32 mL N,N-dimethylformamide (DMF) and MOPS buffer (0.1 M, pH 7.8), and the pH was adjusted to 7.8 with 85% phosphoric acid. The small scale biotransformation with either the whole cells or with the cell lysate was performed in 50 mL falcon tubes in a MOPS buffer (0.1 M, pH 7.8) at 37 °C and 250 rpm. For the whole cells, the concentration of the biocatalyst was 6.83 mg of the dry cell weight (mgDCW) per mL of reaction. The cell lysate was produced using the same amount of dry cell weight as was used for the whole cell biotransformation. If not stated otherwise, the total reaction volume was 2.6 mL. The consumption of THIQ and the formation of DHIQ were monitored by HPLC analysis.
For the determination of kinetic parameters, biotransformations with 2. 3, 5.3, 10.8, 21.4, 31.8, 41 .8 and 48 mM THIQ were performed in duplicates following the above mentioned procedure and the initial reaction rates were calculated. The mean initial rates of the duplicates were calculated and plotted, with the error bars representing the standard deviation. Kinetic parameters Vmax and KM were calculated using the Prism 5 software (GraphPad Software, Inc., CA, USA). 
Optimization of the chemical step
Stability studies
To test the effect of chemocatalysts (CuI and H2O2) on the biocatalyst, stability studies were performed on both cells and lysates of MAO-N D9 and D11 variants. Four sets of reaction mixtures, each of total volume 3.36 mL, were set in 50 mL falcon tubes at 37 °C and 250 rpm. Except for the MOPS buffer (0.1 M, pH 7.8) and the biocatalyst, one contained 1 mol% CuI (21 µL of 40 mM stock solution, 0.00084 mmol) and the other, 10 eq. H2O2 (81.9 µL of 35% solution, 0.84 mmol), while the third contained a combination of 1 mol% CuI + 10 eq. H2O2, and the last one was left as a control without chemical factors. The amount of chemical agents was calculated for the volume sufficient for 3.5 reactions with 20 mM substrate. The concentration of the biocatalyst was equal for the whole cells and the cell lysate and accounted for 6.83 mgDCW per mL of reaction.
1.2 mL standard biotransformations were performed with all setups containing CuI (1 mol%, 0.00024 mmol), H2O2 (10 eq, 0.24 mmol) or both after two, four, and 24 h of incubation as follows: 960 μL of reaction mixture were taken from the stock and 240 μL of 100 mM THIQ stock were added to reach the 20 mM initial substrate concentration. The biotransformation with the control setup without CuI and H2O2 was performed at the beginning of the incubation (t = 0 h) and after 24 h. Samples taken after 3 h of the biotransformation were analyzed using HPLC.
Intermediate product inhibition
The MAO-N D9 cell stock was re-suspended in the MOPS buffer (0.1 M, pH 7.8) to reach a 5x more concentrated suspension than what was required for the biotransformation (6.83 mgDCW/mL). The amine (THIQ) stock solution was prepared as mentioned above. 5 mL of 90 mM imine intermediate product (DHIQ) stock solution was prepared by dissolving 57.6 µL DHIQ in 580 µL DMF and the MOPS buffer (0.1 M, pH 7.8). Prior to starting the biotransformation with 20 mM THIQ, the cell suspension in MOPS was incubated in 50 mL falcon tubes for 15 min with the particular amount of imine to reach 10, 20, 30 and 40 mM final concentration in 2.6 mL total volume of the reaction mixture. By adding the substrate, the biomass concentration was adjusted to 6.83 mgDCW/mL and standard biotransformations in duplicates were performed at 37 °C and 250 rpm. The mean values of the initial rates were calculated and plotted, with the error bars representing standard deviations.
One-pot two step reaction scale-up
The reaction setup (Error! Reference source not found.) was scaled-up to an initial volume of 25 mL and was performed in 250 mL baffled shake flasks at 37 °C and 250 rpm. The MAO-N D9 cell stock was re-suspended in the MOPS buffer (0.1 M, pH 7.8) to reach 5x concentrated suspension, which was further diluted by adding MOPS and a portion of the 100 mM THIQ stock. The biological step was started with a 25 mL reaction volume at standard conditions (biomass concentration 6.83 mgDCW/mL, 20 mM THIQ). After three, six and nine hours, the reaction mixture was supplemented with an amount of 100 mM THIQ stock needed to reach 20 mM, taking into account the increasing reaction volume, irrespective of the remaining substrate from the previous feeding. At each substrate feeding point, the reaction mixture was supplemented with an adequate portion of cells (gDCW) corresponding to the amount that was taken out during the sampling in order to keep the amount (not the concentration) of the biocatalyst constant. The reaction was monitored over time and after 25 h, the shake flasks were removed from the shaker and stored at 4 °C overnight. Taking into account the volume of the chemical agents, a portion of the reaction mixture was removed and the chemical step was started with 45 mM biologically produced DHIQ, 1 mol% CuI (11.25 µL/mLreaction) and 10 eq. H2O2 (43.9 µL/mLreaction). The reaction ran for 24 h and was monitored by HPLC.
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Analytical method
150 μL samples were taken from the reaction mixture. The reaction was quenched by adding 150 μL 0.5% (v/v) trifluoracetic acid (TFA), followed by intensive vortexing and centrifugation (16060 g, 10 min). The samples were diluted with the aqueous mobile phase so that the concentration of each of the analyzed substances was in the range of their calibration curves. Both the biological and chemical reaction steps were monitored via HPLC using the Dionex Ultimate 3000 system equipped with the Ultimate 3000 pump, an autosampler, a UM 3000 RS variable wavelength detector, and an ACE 5 C18 column (150 mm × 4.6 mm, 5 µm particle size; Advance Chromatography Technologies, Aberdeen, UK). MilliQ water and methanol, both containing 0.1% TFA (v/v), were used as mobile phases. The gradient analysis was performed according to the conditions in Error! Not a valid bookmark selfreference. at 30 °C at a constant flow rate of 1 mL/min. The injection volume was 20 µL and the analytes were detected at 260 nm. The quantitative analysis was performed by integration of peak areas using the external standard method. DHIO standard (98%) was purchased from NovoChemy Ltd. (Shanghai, China). The THIQ, DHIQ and DHIO retention times were 7.1 min, 4.2 min and 13.3 min respectively.
Insert Table I .
RESULTS AND DISCUSSION
Selection of the expression strain
MAO-N variants have previously been expressed both in BL21(DE3) Ghislieri et al. 2013a; Köhler et al. 2010 ) and C43(DE3) cells (Ghislieri et al. 2013b; Heath et al. 2016; Schrittwieser et al. 2014) . The preliminary studies focused on the selection of the 
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Considering the costs of biocatalyst production in terms of process scale-up, the aim is to minimize the enzyme purification and operate the process with the crudest form of catalyst possible (Pollard and Woodley 2007) . Although almost the same amount of DHIQ was obtained with MAO-N D9 cells and lysate during each stage of cultivation (Figure 10 ), in order to keep the process simple and avoid the number of procedures, MAO-N D9, in the form of whole cells harvested after 72 h, was selected as a biocatalyst for further use.
The effect of CuI/H2O2 on the biocatalyst
The decision for MAO-N D9 cells to be the biocatalyst of choice for the combination with the chemocatalytic step was also supported by stability studies in the presence of CuI/H2O2 performed on the first reaction step of Error! Reference source not found.. Bechi et al. (2014) used pure MAO-N D9 for the one-pot two-step cascade conversion of cyclic amine (THIQ) to lactam (DHIO). However, no lactam formation was observed when MAO-N D9 whole cells and cell lysate were used for this model chemo-biotransformation, in combination with CuI/H2O2, when all the reagents were mixed in one-pot at the beginning of the reaction. Therefore, the investigation of the effect of CuI, H2O2 and their combination on the MAO-N D9 cells and cell lysate was performed. After 2, 4 and 24 h of incubation of the biocatalyst with CuI, CuI + H2O2 and H2O2, standard biotransformation with 20 mM THIQ was performed. For comparison, control biotransformations were run with the cells and the lysate at t = 0 h and after 24 h of incubation at 37 °C and 250 rpm. Samples were taken after 3 h of biotransformation and the amount of formed imine was compared (Figure 12 ). While the incubation in the presence of 10 eq. H2O2 had almost no effect on the amount of formed imine by MAO-N D9 cells, it was lowered by half in the presence of 1 mol% CuI. In both cases, the contact time did not play a significant role and almost the same amount of imine was formed after 2 and 24 h of incubation ( Figure 12A ), indicating that CuI probably causes deactivation of the biocatalyst in less than 2 h. The combination of 1 mol% CuI and 10 eq. H2O2 had the most harmful effect on MAO-N D9 cells, and only 4.6 mM DHIQ was formed after 2 h incubation. In contrast to the cells, not more than 1.2 mM DHIQ was reached with MAO-N D9 lysate that was previously incubated with the chemical agents ( Figure 12B ), excluding the lysate from further studies. As shown above, MAO-N D9 is sensitive to CuI and H2O2. Unlike the cell lysate, cell membranes of the intact whole cells protect the intracellular enzyme and diminish the negative impact of the chemicals.
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The ratio of CuI and H2O2
When pure MAO-N D9 was used as a biocatalyst in the reaction (Fig. 1) , only the amount of H2O2 was optimized and the best results were reached with 10 eq. . Unlike CuI, H2O2 itself does not negatively affect the activity of MAO-N D9 cells, even after 24 h incubation. It is obvious that the combination of CuI and H2O2 is very harmful for the biocatalyst, even at 2 h of contact (Figure 12 . Figure 12A ). Three combinations of CuI and H2O2 were tested in order to find their optimal ratio and possibly lower the amount for the transformation of 20 mM commercially available DHIQ to lactam (DHIO), which is the desired final product.
The reaction was performed in duplicates in 50 mL falcon tubes with a 2 mL total reaction volume and was monitored over time. The highest concentration of DHIO was reached when 1 mol% CuI and 10 eq. H2O2 were used ( Figure 13 ).
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After 25 h of reaction, the concentration of formed DHIO did not significantly increase compared to 4 h, and reached 13.5 ±3.6 mM (1 mol% CuI + 10 eq. H2O2), 7.8 ±0.1 mM (0.5 mol% CuI + 10 eq. H2O2), and 6.4 ±0.2 mM (0.5 mol% CuI + 0.5 eq. H2O2). Despite the negative effect of the chemical agents on the biocatalyst, in order to keep the reaction effective, it was not possible to lower their amount, as the best results were reached with 1 mol% CuI and 10 eq. H2O2.
Kinetic parameters determination of MAO-N D9 cells
As MAO-N D9 is a relatively new variant of monoamine oxidase (Rowles et al. 2012) , so far only one kinetic study has been performed with the pure enzyme in the one-pot deracemization of the alkaloid (±)-crispine A (Rowles et al. 2012 ). In our study, E. coli towards various secondary amines. The obtained KM values were of the same order of magnitude as our result. Generally speaking, the amine inhibition is the main factor affecting the overall reaction rate and for the purpose of the reaction scale-up it has been suggested to fed-batch the amine substrate. Similar behavior is assumed for the MAO-N D9.
Intermediate product (DHIQ) inhibition
Previous studies performed with the MAO-N variant D5 indicate that the forming cyclic imine product causes inhibition and inactivation of the biocatalyst (Ramesh and Woodley 2014) , although the imine inhibition constants are 1-2 orders of magnitude higher than the corresponding substrate inhibition constants (Rios-Solis et al. 2015) . Another example of irreversible imine inhibition was observed during boceprevir synthesis using the MAON401 variant, after 0.8 mM imine already caused a 40% decrease of activity over time. The inhibition issues were overcome by optimizing the substrate feeding and addition of bisulfite to achieve a trapping of the imine product (Kohls et al. 2014; Li et al. 2012) . It was assumed that imine inhibition might also be the reason why the model reaction could not be performed with whole cells as a one-pot two-step cascade with all the reagents mixed from the beginning of the reaction, as it was possible with the pure enzyme in the study of Bechi et al. (2014) . Therefore, an inhibition study using commercially available imine DHIQ was performed. The biocatalyst was incubated in the presence of DHIQ (11.0, 21.7, 31.8 and 42.5 mM) for 15 min prior to starting the standard biotransformation with 20 mM THIQ. The effect of imine on the biological step of the model reaction was expressed as a relative initial rate compared to the control experiment performed without the addition of DHIQ to the reaction, corresponding to a 100% initial rate. The results prove that the intermediate imine product has an inhibitory effect on MAO-N D9, even at low concentrations and after a short contact time, resulting in an almost 50% decrease of the initial rate at 21.7 mM DHIQ and more than a 70% decrease at 42.5 mM DHIQ (Figure 15 ).
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One-pot two-step chemo-biocatalyzed reaction
As mentioned before, the direct conversion of amine to lactam via one-pot chemobiocatalysis is not possible when MAO-N D9 whole cells are used, and it is necessary to perform the reactions stepwise. The biotransformation step with 20 mM THIQ as a substrate was scaled-up to 250 mL baffled shake flasks and the reaction was started with an initial volume of 25 mL and biomass concentration 6.83 mgDCW/mL. In order to shorten the contact time of the biocatalyst with high substrate concentration and following the recommendation of Rios-Solis et al. (2015) to avoid amine inhibition, feeding strategy was applied during the production of DHIQ. Triple feeding with 20 mM THIQ was performed three, six and nine hours from the start, while the amount of biocatalyst was kept constant by adding the amount of cells that was taken out during the sampling, accounting for 6%, 4.5%, and 3.8%, respectively. The feeding intervals and the amount of added substrate was a compromise between the empirical knowledge about the length of the biotransformation with fresh biocatalyst (~3 h), the already known inhibition effect of DHIQ and the aim to effectively and conveniently produce as much DHIQ as possible. After 25 h of biotransformation, the concentration of DHIQ reached 48.2 mM and the overall yield was 71.3% ( A). The overall yield was calculated as the ratio of micromoles of produced DHIQ to the total amount of micromoles of added THIQ.
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Following the biological production of DHIQ, its chemical conversion to DHIO was employed as a second step in the one-pot system by adding 1 mol% CuI and 10 eq. H2O2 without removing the biocatalyst (Fig. 8B) . The amount of chemical reagents was calculated to correspond to 45 mM imine. This step was performed in the same parallel reaction vessels in which DHIQ was produced. The reaction was monitored for 25 h and the results indicate that more than 70% of DHIO was formed in the first five hours, to reach a final concentration of ~30 mM after 25 h (Error! Reference source not found.). The residual THIQ from the first step remains unaffected in the mixture, and therefore was not involved in the overall yield. This was calculated as the ratio of micromoles of formed DHIO to micromoles of initial DHIQ in the mixture, accounting for 69.4%. Bechi et al. (2014) reached 69% conversion of 40 mM THIQ to DHIO in a one-pot two-step reaction, employing 0.4 mg/mL pure MAO-N D9, where all of the reactants were mixed together from the beginning of the process. In our case, when MAO-N D9 cells were used, although still performed in one-pot, it was necessary to separate the bio-and chemocatalytical step due to intermediate product inhibition of the biocatalyst and its instability in the presence of the chemical catalysts. Therefore, it would be misleading to express the conversion directly from THIQ. As Bechi et al. (2014) demonstrated, the same lactam product could be produced in 94% conversion by also coupling pure MAO-N D9 with E. coli expressing xanthine dehydrogenase. Compared to the previous study, we scaled-up the reaction and modified the analytical method, which has allowed simplification of the sample work up by omitting the extraction step to DMC followed by drying. During the chemical step of the reaction, a loss of cell integrity was observed, as there was almost no pellet present in the samples taken after a couple of hours of reaction and their work up. Despite the inhibition/inactivation effect of the chemical agents, the advantage of this model reaction is the compatibility of reaction conditions for both steps, which are performed at a mild temperature and pH in a buffer aqueous environment. This is more typical for concurrent one-pot chemoenzymatic processes (Denard et al. 2013) .
Despite the different nature of bio-and chemocatalysts, there are ways that they complement each other and work in similar conditions. There is no general model or prediction for the interactions between chemical catalysts and enzymes, as they depend individually on the characteristics of the two catalysts, as well as of the reaction being catalyzed (Denard et al. 2013 ). When it comes to compatibility issues, compartmentalization is one of the ways to minimize the mutual toxic interactions of the bio-and chemocatalyst. One of the options is to separate them in different liquid phases (e.g. ionic liquids) or to isolate them by supporting on organic or inorganic solid-state materials (Marr and Liu 2011) . In the latter case, their reusability might be achieved. Although a chemical catalyst was not involved, in a recent study, we proved that when immobilized, MAO-N whole cells could be repeatedly used for the biotransformation of the model secondary amine (Zajkoska et al. 2015) .
Coupling an electron donor in the reduction step (Foulkes et al. 2011) . This is a novel approach to using synthetic biology tools in the development of organisms for multistep chemobiocatalyzed one-pot reactions involving not only MAO.
Conclusion
In this study, we demonstrated a one-pot two-step conversion of cyclic amine to lactam employing whole cells that express MAO-N coupled with a Cu-based oxidative system.
Taking into account that MAO-N variants have an affinity towards a variety of amine substrates, this proves the concept that the whole cell biocatalyst can be competitive with a pure enzyme and advantageous in terms of scale-up. Compared to pure enzymes, several operational steps are omitted in the production of the biocatalyst. 
